10.1594/PANGAEA.898921Falfushynska, HalinaHalinaFalfushynska0000-0003-3058-4919Sokolov, Eugene PEugene PSokolovHaider, FouziaFouziaHaider0000-0002-5388-6453Oppermann, ChristinaChristinaOppermannKragl, UdoUdoKragl0000-0002-2507-7472Ruth, WolfgangWolfgangRuthStock, MariusMariusStockGlufke, SabrinaSabrinaGlufkeWinkel, Eileen JEileen JWinkelSokolova, Inna MInna MSokolova0000-0002-2068-4302PANGAEA2019Atorvastatinmitochondrial respirationMytilus edulisSpeciesTreatmentTime in weeksSalinityTemperature, waterSample IDTissuesTissue, wet massMitochondrial suspensionBufferOsmolarityProteinsMitochondria, oxygen consumptionRatioDataset10.1016/j.aquatox.2018.12.022528 data pointstext/tab-separated-valuesCreative Commons Attribution 4.0 InternationalIncreasing concentration of biologically active pharmaceutical compounds can affect marine organisms. The bioavailability and environmental stability of these compounds make them potential threat to these organisms, specially the sessile organisms. We have examined the effects of atorvastatin, a globally prescribed drug, on the blue mussels – Mytilus edulis. In this data set, we presents the effect of atorvastatin (ATO) on mitochondrial respiration of Mytilus edulis.